These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
188 related articles for article (PubMed ID: 5664483)
1. ["IB-503"--a drug with antidepressive and anti-manic effect. (Preliminary report)]. Bilikiewicz A; Dolmierski R Psychiatr Pol; 1968; 2(3):283-8. PubMed ID: 5664483 [No Abstract] [Full Text] [Related]
2. [Considerations on the therapeutic management of mixed psychoses and of depressive manifestations symptomatic of schizophrenia]. Scala A Osp Psichiatr; 1967; 35(4):501-34. PubMed ID: 5607254 [No Abstract] [Full Text] [Related]
3. Affective disease health maintenance organization. Patterns of lithium response. Shelley EM; Mendlewicz J; Fieve RR N Y State J Med; 1974 Sep; 74(10):1766-8. PubMed ID: 4606182 [No Abstract] [Full Text] [Related]
4. [Effects of amitriptyline on the metabolism of catecholamines and serotonin in depressed patients]. Bruno A; Cumer Bruno S Riv Neurobiol; 1969; 15(4):749-61. PubMed ID: 5403687 [No Abstract] [Full Text] [Related]
5. [Problems of differentiated thymoleptic therapy in phasic depressions]. Smulevich AB; Vorob'ev VIu; Zavidovskaia GI; Lobova EK; Balashova MG Zh Nevropatol Psikhiatr Im S S Korsakova; 1974; 74(6):912-8. PubMed ID: 4454918 [No Abstract] [Full Text] [Related]
6. A preliminary investigation of WY-3263 versus amitriptyline in depressions. Sterlin C; Lehmann HE; Oliveros RF; Ban TA; Saxena BM Curr Ther Res Clin Exp; 1968 Nov; 10(11):576-82. PubMed ID: 4973974 [No Abstract] [Full Text] [Related]
7. [Clinical study of an anxiolytic antidepressive drug]. Bolzani L; Slivar G Psychiatr Neurol (Basel); 1967; 153(5):301-7. PubMed ID: 5339994 [No Abstract] [Full Text] [Related]
8. [The changes in the interaction of the brain hemispheres in the course of drug therapy of psychosis]. Ivanov OV Zh Evol Biokhim Fiziol; 2003; 39(1):104-9. PubMed ID: 12739274 [No Abstract] [Full Text] [Related]
9. [The treatment of endogenous depression with monochlorimipramin]. Arnold OH; Heves HP Wien Klin Wochenschr; 1967 Jan; 79(1):3-6. PubMed ID: 5340280 [No Abstract] [Full Text] [Related]
10. [Study of an antidepressive agent in psychiatry: Mutabon F]. Bourgeois M Ann Med Psychol (Paris); 1967 Jul; 125(2):318-26. PubMed ID: 6076196 [No Abstract] [Full Text] [Related]
11. [The comparative efficacy of Aurorix and amitriptyline in treating depressions]. Iakovlev VA Voen Med Zh; 1997 Apr; 318(4):37-8. PubMed ID: 9221592 [No Abstract] [Full Text] [Related]
13. [Preliminary study of the action of thyrotropin releasing hormone (TRH) in depressive states]. Deniker P; Ginestet D; Lôo H; Zarifian E; Cottereau MJ Ann Med Psychol (Paris); 1974 Feb; 1(2):249-55. PubMed ID: 4211567 [No Abstract] [Full Text] [Related]
14. [Experience with the use of acrichine in patients in depressive states and catatonis(preliminary report)]. Grudev FI Zh Nevropatol Psikhiatr Im S S Korsakova; 1966; 66(10):1565-71. PubMed ID: 6000321 [No Abstract] [Full Text] [Related]
15. [1st results with a new antidepressive drug FI6654]. Lo Grasso G; Losavio T; Matteucci A Acta Neurol (Napoli); 1972; 27(4):403-22. PubMed ID: 5085164 [No Abstract] [Full Text] [Related]